In the present study, a graphene organic framework (GOF-LS) was successfully prepared by cross-linking nanosheets of graphene oxide (GO) with dimethyl-4,4′-(methylenebis (2-thioxo-2,3-dihydro-1H-imidazole-3,1-diyl)) dibutyrate (LS) as a pillaring agent via a transesterification process. GOF-LS have been characterized by various analyses, such as Fourier transform infrared, BET, powder X-ray diffraction, energy-dispersive X-ray, thermogravimetric analysis, and FE-SEM. The oxygenic functional groups in GO and the sulfur atoms of LS give mesoporous GOF-LS a strong affinity for iodine molecules due to the formation of charge-transfer complexes between the host framework's sulfur and oxygen atoms and the guest iodine molecules. Therefore, GOF-LS exhibited a high adsorption capacity of 1315.105 mg/g for removing iodine from the iodine/cyclohexane solution. In addition, GOF-LS also displayed extraordinary stability toward iodine, with an excellent capacity of 232 wt % for volatile iodine. To the best of our knowledge, this is the first report aiming at iodine uptake with a GOF built on a thioamide-based ligand. This study also aimed to investigate the antibacterial properties of GOF-LS. The antibacterial activity of GOF-L suspensions (80 μg/mL) was tested against four species of bacteria, including two Gram-negative (Escherichia coli, Pseudomonas aeruginosa) and two Gram-positive (Bacillus subtilis, Staphylococcus aureus). The results indicated that the GOF-LS were effective against all bacterial species, with especially remarkable growth inhibition against Gram-positive bacteria. In addition, GOF-LS demonstrated promising results in controlling antibiotic-resistant strains of E. coli and S. aureus in the environment. This study will contribute to the development of a cost-effective, metal-free, stable, and environmentally friendly multifunctional framework for the remediation of iodine-containing pollutants and the control of bacterial infections, addressing critical needs in environmental protection and public health.
No takes yet. Share an insight, caveat, or question.
Naseri et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: